siRNA, Anti-NNAT, 2'-OMe/2'-MOE/LNA/Ribo/Backbone-modified(CAT#: SIRGT16057WQ-2OMe)

The product SIRGT16057WQ-2OMe is a type of small interfering RNA (siRNA) that targets NNAT gene and regulates the expression of gene. The siRNA interferes with the expression of NNAT gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_001322802.1; NM_005386.3; NM_181689.2
Alternative Names Peg5
Related Diseases Myoclonic Epilepsy Of Lafora
Purification HPLC
Target Gene
Gene ID 4826
Uniprot ID Q16517
Sub Cat Target Species Modification Scale  
SIRGT18057WQ-2MOE NNAT Human 2'-O-methoxyethyl (2'-MOE) Inquiry
SIRGT19057WQ-LNA NNAT Human Locked Nucleic Acid (LNA) Inquiry
SIRGT16057WQ-RB NNAT Human Ribo-modified Inquiry
SIRGT17057WQ-BB NNAT Human Backbone-modified Inquiry

Related Products